Phase Forward (NASDAQ: PFWD) today announced that GlaxoSmithKline (NYSE: GSK) has signed multi-year, multi-million dollar contracts covering ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE